In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
Takashi Miura(The University of Tokyo), Hiroaki Suga(The University of Tokyo)
Cited by 50
Related Papers
Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme
|Nature|2008|152
Artificial human Met agonists based on macrocycle scaffolds
|Nature Communications|2015|118
GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf
|ACS Central Science|2020|118
Confronting risks of mirror life
|Science|2024|80